Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 45.06 USD -0.92% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Amphastar Pharmaceuticals Inc?
Write Note

Amphastar Pharmaceuticals Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amphastar Pharmaceuticals Inc
Accounts Payable Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Accounts Payable
$31.8m
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
6%
Johnson & Johnson
NYSE:JNJ
Accounts Payable
$9B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Accounts Payable
$3.5B
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
3%
Pfizer Inc
NYSE:PFE
Accounts Payable
$5.1B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
6%
Merck & Co Inc
NYSE:MRK
Accounts Payable
$3.6B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
5%
Eli Lilly and Co
NYSE:LLY
Accounts Payable
$2.9B
CAGR 3-Years
23%
CAGR 5-Years
21%
CAGR 10-Years
11%

See Also

What is Amphastar Pharmaceuticals Inc's Accounts Payable?
Accounts Payable
31.8m USD

Based on the financial report for Jun 30, 2024, Amphastar Pharmaceuticals Inc's Accounts Payable amounts to 31.8m USD.

What is Amphastar Pharmaceuticals Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
6%

Over the last year, the Accounts Payable growth was 69%. The average annual Accounts Payable growth rates for Amphastar Pharmaceuticals Inc have been 5% over the past three years , and 6% over the past ten years .

Back to Top